Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on lewis acid catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113336792A reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonates, offering superior stereoselectivity and yield for pharmaceutical manufacturing.
Patent CN1205196C reveals a novel C(10) selective acylation method for 10-DAB. Discover cost-effective taxane intermediate manufacturing and supply chain advantages.
Patent CN102146097A reveals a solvent-free DOPO synthesis route. Achieve >99% purity with reduced equipment costs for polymer additive manufacturing.
Patent CN116040592A reveals a novel LiFSI preparation method using lithium alloys, offering superior purity and simplified processing for reliable battery electrolyte suppliers.
Novel metal-free C5 iodination of indoles using NIS or I2. High regioselectivity, mild conditions. Ideal for API intermediates. Cost-effective scale-up.
Novel Lewis acid catalyzed route for Everolimus reduces steps and improves purity. Ideal for pharmaceutical intermediates supply chain cost reduction and scale-up.
Advanced synthesis of 2-chloro-4-(4-chlorophenoxy)-acetophenone via patent CN113816838A. Delivers high purity, optimized solvent recovery, and cost-effective manufacturing for global agrochemical supply chains.
Patent CN113336792B reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonate compounds, offering superior stereoselectivity and scalable manufacturing for NASH therapeutics.
Patent CN117947113A reveals dynamic kinetic resolution for high purity chiral intermediates. Enables cost reduction in pharmaceutical manufacturing with scalable enzyme catalysis.
Patent CN112812087A reveals a high-yield 3-step synthesis for Boseine. This method ensures superior purity and cost efficiency for cosmetic active ingredient manufacturing.
Patent CN102219803A details a novel nitrone-based route for Ezetimibe intermediates, offering superior stereocontrol and reduced raw material consumption for pharmaceutical manufacturing.
Novel boron-catalyzed method for meta-cyano pyridines. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN1169418A details a novel Lewis acid-catalyzed condensation for polyene esters, offering superior gamma-selectivity and cost reduction in carotenoid manufacturing compared to Wittig reactions.
Patent CN116003407A reveals a scalable Zolpidem synthesis using PBr3-Lewis Acid catalysis, offering high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114773309A details a high-yield synthesis of Hepatitis C intermediates using Lewis acid catalysis, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN103539827B details high-yield thiooligosaccharide synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103193608A details a high-yield veratraldehyde synthesis route offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN105130982A reveals efficient synthesis route. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing with high purity.
Patent CN106146535A reveals a novel Lewis acid-catalyzed route for Everolimus. This method ensures high purity, reduced steps, and scalable supply chain reliability for global buyers.
Novel CrCl3-catalyzed route for (S)-phenylglycinol hydrochloride. Enhances purity and reduces costs for pharmaceutical intermediate manufacturing.